An Open-Label, Phase 1 Study Evaluating the Safety and Pharmacokinetics of Pralatrexate in Relapsed/Refractory Advanced Solid Tumors or Advanced Lymphoma/Myeloma Patients with Mild, Moderate, and Severe Renal Impairment

被引：0
|
作者：
Kelly, Kevin R. [1 ]
Gabrail, Nashat Y. [2 ]
Edenfield, William J. [3 ]
Lockhart, A. Craig [4 ]
Olszanski, Anthony J. [5 ]
Reddy, Guru [6 ]
机构：
[1] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
[2] Gabrail Canc Ctr, Canton, OH USA
[3] Canc Ctr Carolinas, Greenville, SC USA
[4] Washington Univ, Sch Med, St Louis, MO 63130 USA
[5] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA
[6] Spectrum Pharmaceut, Irvine, CA USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Pharmacodynamic and Pharmacokinetic Study of Verinurad in Adult Male Subjects with Mild, Moderate, and Severe Renal Impairment: A Phase 1, Open-Label Study
    Smith, William B.
    Hall, Jesse
    Berg, Jolene
    Kazimir, Michal
    Yamamoto, Amy
    Lee, Caroline
    Walker, Susan
    Marbury, Thomas C.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [32] Phase 1, open-label, dose-escalation study of sorafenib in combination with eribulin in patients with advanced, metastatic, or refractory solid tumors
    Frederik Marmé
    Carlos Gomez-Roca
    Kristina Graudenz
    Funan Huang
    John Lettieri
    Carol Peña
    Zuzana Jirakova Trnkova
    Jan Eucker
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 727 - 737
  • [33] Phase 1, open-label, dose-escalation study of sorafenib in combination with eribulin in patients with advanced, metastatic, or refractory solid tumors
    Marme, Frederik
    Gomez-Roca, Carlos
    Graudenz, Kristina
    Huang, Funan
    Lettieri, John
    Pena, Carol
    Trnkova, Zuzana Jirakova
    Eucker, Jan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (04) : 727 - 737
  • [34] A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
    Anthony W. Tolcher
    Leonard J. Appleman
    Geoffrey I. Shapiro
    Alain C. Mita
    Frank Cihon
    Arthur Mazzu
    Pavur R. Sundaresan
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 751 - 764
  • [35] A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
    Tolcher, Anthony W.
    Appleman, Leonard J.
    Shapiro, Geoffrey I.
    Mita, Alain C.
    Cihon, Frank
    Mazzu, Arthur
    Sundaresan, Pavur R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 751 - 764
  • [36] A Phase 1 Study of 131I-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors: Dosimetry, Biodistribution, Pharmacokinetics, and Safety
    Grudzinski, Joseph J.
    Titz, Benjamin
    Kozak, Kevin
    Clarke, William
    Allen, Ernest
    Trembath, LisaAnn
    Stabin, Michael
    Marshall, John
    Cho, Steve Y.
    Wong, Terence Z.
    Mortimer, Joanne
    Weichert, Jamey P.
    PLOS ONE, 2014, 9 (11):
  • [37] A Phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: Dosimetry, biodistribution, pharmacokinetics, and safety
    Grudzinski, Joseph
    Titz, Benjamin
    Kozak, Kevin
    Clarke, William
    Stabin, Michael
    Marshall, John
    Cho, Steve
    Wong, Terence
    Mortimer, J.
    Weichert, Jamey
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [38] Phase I, open-label study of olaparib plus cisplatin in patients with advanced solid tumors
    Balmana, Judith
    Tung, Nadine M.
    Isakoff, Steven J.
    Grana, Begona
    Ryan, Paula D.
    Rafi, Rezvan
    Tracy, Michael
    Winer, Eric
    Baselga, Jose
    Garber, Judy Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Phase 1, Open-Label, Dose Escalation, Safety, and Pharmacokinetics Study of ME-344 as a Single Agent in Patients With Refractory Solid Tumors
    Bendell, Johanna C.
    Patel, Manish R.
    Infante, Jeffrey R.
    Kurkjian, Carla D.
    Jones, Suzanne F.
    Pant, Shubham
    Burris, Howard A., III
    Moreno, Ofir
    Esquibel, Vanessa
    Levin, Wendy
    Moore, Kathleen N.
    CANCER, 2015, 121 (07) : 1056 - 1063
  • [40] A multicenter, open-label, phase 1a study of HC-5404 in patients with advanced solid tumors
    Dudek, Arkadiusz Z.
    O'Shaughnessy, Joyce
    Piha-Paul, Sarina A.
    Uprety, Dipesh
    Kitchens, Benjamin Lee
    Hutson, Thomas E.
    Rank, Brian H.
    Stokes, Michael
    Dudgeon, Crissy
    Surguladze, David
    Lightcap, Eric
    Drees, Jeremy
    Harrison, Ben
    Li, Richard
    LaCayo, Ashley
    Mattson, Paulette
    Bose, Nandita
    Karim, Dhamina
    Gargano, Michele Anne
    Iglesias, Jose Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345